Jul 15, 2020 - This collection features AFP content on heart failure and related issues, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARBs), cardiomyopathy, cardioverter-defibrillators, congestive heart failure, and diastolic and systolic heart failure. This...
- Screening and Diagnosis
- Complications and Special Situations
- Editorials and Letters
- Patient Education, Self-Care
- Other AFP Content
American Family Physician : AFP By Topic
Jul 15, 2020 - Dapagliflozin can be added to existing treatment to reduce the risk of hospitalization for heart failure in patients with type 2 diabetes who have established CVD or are at high risk of CVD. It may also decrease the risk of renal disease progression and death from renal failure.
American Family Physician : STEPS
navigate_before 1 navigate_next